Clinical Trial Update: Study of the Cardiometabolic Effects of Obesity Pharmacotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating cardiometabolic effects of obesity pharmacotherapy in obesity and hypertension populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Obesity, Blood Pressure | Phase 4 | Status: UNKNOWN